MCR-1 is a plasmid-encoded phosphoethanolamine transferase able to modify the lipid A structure. It confers resistance to colistin and was isolated from human, animal, and environmental strains of , raising serious global health concerns. In this paper, we used recombinant -expressing to study the impact of MCR-1 products on -induced activation of inflammatory pathways in activated THP-1 cells, which was used as a model of human macrophages. We found that infection with recombinant -expressing significantly modulated p38-MAPK and Jun N-terminal protein kinase (JNK) activation and pNF-κB nuclear translocation as well as the expression of genes for the relevant proinflammatory cytokines tumor necrosis factor alpha (TNF-α), interleukin-12 (IL-12), and IL-1β compared with -negative strains. Caspase-1 activity and IL-1β secretion were significantly less activated by -positive strains than the -negative parental strain. Similar results were obtained with clinical isolates of -positive , suggesting that, in addition to colistin resistance, the expression of allows the escape of early host innate defenses and may promote bacterial survival.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375756 | PMC |
http://dx.doi.org/10.1128/IAI.00018-20 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!